Related Experiment Videos
Gram-negative pathogens in septicaemic infections
Scandinavian Journal of Infectious Diseases. Supplementum
|January 1, 1982
Summary
Gram-negative rod bacteremia, particularly from Pseudomonas aeruginosa, causes high mortality in hospitalized patients. Research suggests antiserum against endotoxin antigens may be effective for prophylaxis and treatment.
Area of Science:
- Infectious Diseases
- Microbiology
- Immunology
Background:
- Gram-negative rod bacteremia is a significant cause of mortality in hospitalized patients, with Pseudomonas aeruginosa often associated with the highest fatality rates.
- Gastrointestinal colonization, especially with P. aeruginosa, increases the risk of systemic infection in neutropenic patients.
- Microbial virulence factors and host immune responses, including antibody deficiencies and complement pathway activation, play crucial roles in gram-negative infections.
Purpose of the Study:
- To review the current understanding of microbial pathogenetic factors in gram-negative bacillary infections.
- To explore the role of host immune responses and potential therapeutic strategies, such as antiserum against endotoxins.
- To highlight the need for further research into effective treatments for gram-negative bacteremia.
Main Methods:
- Literature review of studies on gram-negative rod bacteremia, focusing on epidemiology, pathogenesis, and treatment.
- Analysis of microbial virulence factors (e.g., O and K antigens, Exotoxin A) and host immune mechanisms (e.g., phagocytosis, complement pathway).
- Evaluation of evidence for antiserum therapy against endotoxin antigens.
Main Results:
- Commonly isolated organisms include Escherichia coli, Klebsiella-Enterobacter-Serratia, and Pseudomonas aeruginosa.
- Host factors like antibody deficiency and impaired complement activation contribute to susceptibility.
- Humoral antitoxic antibodies and antibodies to capsular antigens show correlation with improved prognosis; antiserum against endotoxins shows potential therapeutic benefit.
Conclusions:
- Gram-negative bacteremia remains a critical challenge with high mortality.
- Understanding virulence factors and host immunity is key to developing effective interventions.
- Further research into antiserum therapy against endotoxin antigens is warranted to improve patient outcomes.